Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of High Plasmatic 3-O-Methyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency (Aromatic L-Amino Acid Decarboxylase)

NCT05211609 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05211609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05211609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of High Plasmatic 3-O-Methyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency (Aromatic L-Amino Acid Decarboxylase)
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Unknown status
Start date
May 20, 2022
Completion date
November 1, 2024
Enrollment
388 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aromatic l-amino acid decarboxylase deficiency